Nordic Bioscience

Herlev, Denmark Specialty Founded 1997 51-200 employees

Danish biomarker CRO specializing in neoepitope biomarker technologies for tissue remodeling, conducting clinical trials in rheumatology, musculoskeletal, and metabolic disease with CAP-accredited laboratories.

Services

CLINICAL

Phase II Clinical Trials Phase III Clinical Trials Clinical Data Management Biostatistics

ANALYTICAL

Bioanalytical Testing Method Development & Validation

Therapeutic Areas

Musculoskeletal Metabolic Disease Cardiovascular Inflammation

Contact

Locations

Herlev, Denmark

Certifications

GCP Compliant ISO 9001 CAP

Regulatory Experience

FDAEMA